BOULDER, Colo., Nov. 5, 2020 — BDSA, the leading provider of cannabis industry market intelligence and insights, following last night’s election, announces the potential impact and revenues for the five states that passed ballot measures or initiatives permitting the possession of cannabis by adults.

 

To arrange an interview with a BDSA subject expert, please click here.

 

Here are several predictions and observations coming out of Tuesday’s U.S. election:

 

  • BDSA accurately predicted 4 of 5 new legalizations in 2021. BDSA did not expect the Montana initiative to hit the ballot this election round.
    • The following changes in status based on the election:
      • Arizona – Voters approved a ballot measure to legalize recreational cannabis
      • Mississippi – Voters passed a citizen-sponsored initiative to legalize medical cannabis, bypassing a similar ballot measure created by the state legislature
      • New Jersey – Voters approved a ballot measure to legalize recreational marijuana, the first Mid-Atlantic state to do so
      • Montana – Voters approved a ballot measure to legalize recreational marijuana
      • South Dakota – Voters approved ballot measures to legalize both recreational and medicinal cannabis use, the first state to approve both uses in one initiative
    • BDSA predicts federal legalization in 2022. However, they expect that state legislation and approval will keep the category momentum in 2021.

 

  • Cannabis legalization is an issue that crosses party lines. Four of the five states that legalized marijuana in this election voted red in the 2016 election. This is a reflection that 51% of even the most conservative members of the population support some form of legalization for adults (medical or recreational).

 

  • The next biggest question is when these newly recreational legal states can start selling products to consumers. In recent history, the fastest this has happened has been ~6 months but has taken up to several years. Hot markets to watch in 2021:

 

  • Arizona will be a key state to watch in 2021, as it is one of the oldest and most robust medical marijuana markets in the country.
    • In 2019, sales at Arizona’s 130 dispensaries reached $700 million and in 2020 BDSA predicts they will reach nearly $1 billion. Existing medical dispensaries will be given priority to apply for recreational licenses starting January 19, 2021, with regulation for recreational use expected to be ready by April.
    • However, BDSA recommends cannabis product manufacturers and retailers watch carefully for pushback from the state legislators in the coming weeks which could impact availability in 2021.

 

  • In New Jersey, the big question for cannabis product manufacturers and retailers will be around how fast regulations will be set as no timeline has been established. While medical dispensaries will have the first right to permits, there are currently less than 10 in the state of New Jersey compared to 130 in Arizona.

 

  • While New York legalization did not happen in 2020, Governor Cuomo has stated that cannabis legalization will be part of 2021 budget, which would be approved in March or April. BDSA projects it to be the sixth largest market by 2025 just behind already established markets such as Arizona, California, Colorado, Florida and Illinois.

 

About BDSA

Headquartered in Boulder, Colorado, BDSA helps businesses improve revenues, reduce innovation risk, and prioritize market expansion with accurate and actionable cannabis market intelligence and consumer research. The company provides a holistic understanding of the cannabis market by generating insights from point-of-sale data, consumer research, and market-wide industry projections. To learn more please visit www.bdsa.com.

 

BDSA Contact                                                          

Rachel Nicolas            

UPRAISE Marketing + PR for BDSA

bdsa@upraisepr.com

415-397-7600